Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit

Background: Proton Pump Inhibitors (PPIs) are the most common medicine for the treatment and prophylaxis of acid peptic conditions. The inappropriate use of the PPIs, mainly the intravenous form of pantoprazole may lead to excessive cost and unexpected adverse effects. Objectives: The present stud...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gohar Eslami, Elahe Karimpour Razkenari, Yahya Sharifi, Aria Soleimani, Ebrahim Salehifar, Parastoo Karimi Aliabadi
Formato:	article
Lenguaje:	EN
Publicado:	Mazandaran University of Medical Sciences 2021
Materias:	pantoprazole drug use evaluation cardiovascular disease peptic ulcer Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/ff093cf5717f44bba2ad49dc2fd4dd53
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ff093cf5717f44bba2ad49dc2fd4dd53
record_format	dspace
spelling	oai:doaj.org-article:ff093cf5717f44bba2ad49dc2fd4dd532021-11-07T16:08:01ZClinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit2423-4494https://doaj.org/article/ff093cf5717f44bba2ad49dc2fd4dd532021-02-01T00:00:00Zhttps://pbr.mazums.ac.ir/article-1-366-en.htmlhttps://doaj.org/toc/2423-4494Background: Proton Pump Inhibitors (PPIs) are the most common medicine for the treatment and prophylaxis of acid peptic conditions. The inappropriate use of the PPIs, mainly the intravenous form of pantoprazole may lead to excessive cost and unexpected adverse effects. Objectives: The present study aimed to evaluate the use of intravenous pantoprazole in the International Heart Center in the north of Iran. Methods: The current retrospective study was performed on 215 patients hospitalized in Fatemeh Zahra Hospital in Sari City, Iran. Patients’ demographics, the type and doses of pantoprazole, and other relevant clinical data were recorded from their documentation. The appropriate use of pantoprazole was evaluated according to recommendations provided by Medscape 2020, and UpToDate 2020. Results: Prescribing PPI was appropriate for 53.5% of the examined patients; however, the majority of intravenous prescription cases were inappropriate (76.7%). Oral PPIs could have been used in 93.5% of the cases; however, they received the parenteral form of pantoprazole. The main cause of pantoprazole prescription in the explored hospital was stress ulcer prophylaxis, with the median 4/18 days used, which internal specialists in most of the cases (45.6%) prescribed. Conclusion: In the current study, administrating intravenous pantoprazole was inappropriate in most of the cases. As a result of this improper administration, the extensive cost is exposed to the healthcare system, i.e., likely to be unsafe for patients. Accordingly, risk and indication evaluation for the prescription of pantoprazole should be a priority in each patient. Finally, it seems necessary to determine a protocol for PPI prescription per hospital for the rational use of drugs. Gohar EslamiElahe Karimpour Razkenari Yahya SharifiAria SoleimaniEbrahim SalehifarParastoo Karimi AliabadiMazandaran University of Medical Sciencesarticlepantoprazoledrug use evaluationcardiovascular diseasepeptic ulcerTherapeutics. PharmacologyRM1-950ENPharmaceutical and Biomedical Research, Vol 7, Iss 3, Pp 183-190 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	pantoprazole drug use evaluation cardiovascular disease peptic ulcer Therapeutics. Pharmacology RM1-950
spellingShingle	pantoprazole drug use evaluation cardiovascular disease peptic ulcer Therapeutics. Pharmacology RM1-950 Gohar Eslami Elahe Karimpour Razkenari Yahya Sharifi Aria Soleimani Ebrahim Salehifar Parastoo Karimi Aliabadi Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit
description	Background: Proton Pump Inhibitors (PPIs) are the most common medicine for the treatment and prophylaxis of acid peptic conditions. The inappropriate use of the PPIs, mainly the intravenous form of pantoprazole may lead to excessive cost and unexpected adverse effects. Objectives: The present study aimed to evaluate the use of intravenous pantoprazole in the International Heart Center in the north of Iran. Methods: The current retrospective study was performed on 215 patients hospitalized in Fatemeh Zahra Hospital in Sari City, Iran. Patients’ demographics, the type and doses of pantoprazole, and other relevant clinical data were recorded from their documentation. The appropriate use of pantoprazole was evaluated according to recommendations provided by Medscape 2020, and UpToDate 2020. Results: Prescribing PPI was appropriate for 53.5% of the examined patients; however, the majority of intravenous prescription cases were inappropriate (76.7%). Oral PPIs could have been used in 93.5% of the cases; however, they received the parenteral form of pantoprazole. The main cause of pantoprazole prescription in the explored hospital was stress ulcer prophylaxis, with the median 4/18 days used, which internal specialists in most of the cases (45.6%) prescribed. Conclusion: In the current study, administrating intravenous pantoprazole was inappropriate in most of the cases. As a result of this improper administration, the extensive cost is exposed to the healthcare system, i.e., likely to be unsafe for patients. Accordingly, risk and indication evaluation for the prescription of pantoprazole should be a priority in each patient. Finally, it seems necessary to determine a protocol for PPI prescription per hospital for the rational use of drugs.
format	article
author	Gohar Eslami Elahe Karimpour Razkenari Yahya Sharifi Aria Soleimani Ebrahim Salehifar Parastoo Karimi Aliabadi
author_facet	Gohar Eslami Elahe Karimpour Razkenari Yahya Sharifi Aria Soleimani Ebrahim Salehifar Parastoo Karimi Aliabadi
author_sort	Gohar Eslami
title	Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit
title_short	Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit
title_full	Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit
title_fullStr	Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit
title_full_unstemmed	Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit
title_sort	clinical characteristics of intravenous pantoprazole consumption in cardiac intensive care unit
publisher	Mazandaran University of Medical Sciences
publishDate	2021
url	https://doaj.org/article/ff093cf5717f44bba2ad49dc2fd4dd53
work_keys_str_mv	AT gohareslami clinicalcharacteristicsofintravenouspantoprazoleconsumptionincardiacintensivecareunit AT elahekarimpourrazkenari clinicalcharacteristicsofintravenouspantoprazoleconsumptionincardiacintensivecareunit AT yahyasharifi clinicalcharacteristicsofintravenouspantoprazoleconsumptionincardiacintensivecareunit AT ariasoleimani clinicalcharacteristicsofintravenouspantoprazoleconsumptionincardiacintensivecareunit AT ebrahimsalehifar clinicalcharacteristicsofintravenouspantoprazoleconsumptionincardiacintensivecareunit AT parastookarimialiabadi clinicalcharacteristicsofintravenouspantoprazoleconsumptionincardiacintensivecareunit
_version_	1718443328048988160

Clinical Characteristics of Intravenous Pantoprazole Consumption in Cardiac Intensive Care Unit

Ejemplares similares